Peroxisome proliferator-activated receptor -β/δ, -γ Agonists and resveratrol modulate hypoxia induced changes in nuclear receptor activators of muscle oxidative metabolism

PPAR Research

Volumn , Issue , 2010, Pages

  Regnault, Timothy R H ^a   Zhao, Lin ^a   Chiu, Jacky S S ^a   Gottheil, Stephanie K ^a   Foran, Allison ^a   Yee, Siu Pok ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARNITINE PALMITOYLTRANSFERASE I; CELL NUCLEUS RECEPTOR; FATTY ACID; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RESVERATROL; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR GAMMA; ROSIGLITAZONE; SIRTUIN 1; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; GENETIC TRANSCRIPTION; HYPOXIA; INSULIN SENSITIVITY; MUSCLE METABOLISM; MYOBLAST; NONHUMAN; OXYGEN TENSION; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; RNA TRANSLATION;

EID: 79251587449     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/129173     Document Type: Article

References (65)

1. Fernandez-Twinn D. S., Ozanne S. E., Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome Physiology and Behavior 2006 88 3 234 243
2. Hofman P. L., Cutfield W. S., Robinson E. M., Bergman R. N., Menon R. K., Sperling M. A., Gluckman P. D., Insulin resistance in short children with intrauterine growth retardation Journal of Clinical Endocrinology and Metabolism 1997 82 2 402 406
3. Jaquet D., Gaboriau A., Czernichow P., Levy-Marchal C., Insulin resistance early in adulthood in subjects born with intrauterine growth retardation Journal of Clinical Endocrinology and Metabolism 2000 85 4 1401 1406
4. Barker D. J.P., The developmental origins of insulin resistance Hormone Research 2005 64 supplement 3 2 7
5. Brns C., Jensen C. B., Storgaard H., Alibegovic A., Jacobsen S., Nilsson E., Astrup A., Quistorff B., Vaag A., Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight Journal of Clinical Endocrinology and Metabolism 2008 93 10 3885 3892
6. Szendroedi J., Schmid A. I., Chmelik M., Toth C., Brehm A., Krssak M., Nowotny P., Wolzt M., Waldhausl W., Roden M., Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes PLoS Medicine 2007 4 5, article e154
7. Norris A. W., Chen L., Fisher S. J., Szanto I., Ristow M., Jozsi A. C., Hirshman M. F., Rosen E. D., Goodyear L. J., Gonzalez F. J., Spiegelman B. M., Kahn C. R., Muscle-specific PPAR -deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones The Journal of Clinical Investigation 2003 112 4 608 618
8. Muoio D. M., Koves T. R., Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 : implications for metabolic disease Applied Physiology, Nutrition and Metabolism 2007 32 5 874 883
9. Schuler M., Ali F., Chambon C., Duteil D., Bornert J.-M., Tardivel A., Desvergne B., Wahli W., Chambon P., Metzger D., PGC1 expression is controlled in skeletal muscles by PPAR, whose ablation results in fiber-type switching, obesity, and type 2 diabetes Cell Metabolism 2006 4 5 407 414
10. Smith A. G., Muscat G. E. O., Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease International Journal of Biochemistry and Cell Biology 2005 37 10 2047 2063
11. Gerhart-Hines Z., Rodgers J. T., Bare O., Lerin C., Kim S.-H., Mostoslavsky R., Alt F. W., Wu Z., Puigserver P., Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1 The EMBO Journal 2007 26 7 1913 1923
12. Sugden M. C., Caton P. W., Holness M. J., PPAR control: it's SIRTainly as easy as PGC Journal of Endocrinology 2010 204 2 93 104
13. Pagel-Langenickel I., Bao J., Joseph J. J., Schwartz D. R., Mantell B. S., Xu X., Raghavachari N., Sack M. N., PGC-1 integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle The Journal of Biological Chemistry 2008 283 33 22464 22472
14. Patti M. E., Butte A. J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E. J., Goldfine A. B., Mun E., DeFronzo R., Finlayson J., Kahn C. R., Mandarino L. J., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1 Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471
15. Mandard S., Muller M., Kersten S., Peroxisome proliferator-activated receptor alpha target genes Search ResultsCellular and Molecular Life Sciences 2004 61 393 416
16. Kliewer S. A., Xu H. E., Lambert M. H., Willson T. M., Peroxisome proliferator-activated receptors: from genes to physiology Recent Progress in Hormone Research 2001 56 239 263
17. Macdonald N., Holden P. R., Roberts R. A., Addition of peroxisome proliferator-activated receptor to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators Cancer Research 1999 59 19 4776 4780
18. Bruce C. R., Hoy A. J., Turner N., Watt M. J., Allen T. L., Carpenter K., Cooney G. J., Febbraio M. A., Kraegen E. W., Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance Diabetes 2009 58 3 550 558
19. Samec S., Seydoux J., Dulloo A. G., Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? The FASEB Journal 1998 12 9 715 724
20. Garca-Martinez C., Sibille B., Solanes G., Darimont C., Mac K., Villarroya F., Gmez-Foix A. M., Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation TheFASEB Journal 2001 15 11 2033 2035
21. Hulver M. W., Dohm G. L., The molecular mechanism linking muscle fat accumulation to insulin resistance Proceedings of the Nutrition Society 2004 63 2 375 380
22. Kim J.-Y., Hickner R. C., Cortright R. L., Dohm G. L., Houmard J. A., Lipid oxidation is reduced in obese human skeletal muscle American Journal of Physiology 2000 279 5 E1039 E1044
23. Luquet S., Lopez-Soriano J., Holst D., Fredenrich A., Melki J., Rassoulzadegan M., Grimaldi P. A., Peroxisome proliferator-activated receptor controls muscle development and oxidative capability The FASEB Journal 2003 17 15 2299 2301
24. Jaquet D., Deghmoun S., Chevenne D., Collin D., Czernichow P., Lvy-Marchal C., Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth Diabetologia 2005 48 5 849 855
25. Lane R. H., Maclennan N. K., Daood M. J., Hsu J. L., Janke S. M., Pham T. D., Puri A. R., Watchko J. F., IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor- coactivator-1 gene expression in a fiber specific manner Pediatric Research 2003 53 6 994 1000
26. Louey S., Cock M. L., Harding R., Long term consequences of low birthweight on postnatal growth, adiposity and brain weight at maturity in sheep Journal of Reproduction and Development 2005 51 1 59 68
27. Paolini C. L., Marconi A. M., Ronzoni S., Di Noio M., Fennessey P. V., Pardi G., Battaglia F. C., Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies Journal of Clinical Endocrinology and Metabolism 2001 86 11 5427 5432
28. Regnault T. R. H., de Vrijer B., Galan H. L., Wilkening R. B., Battaglia F. C., Meschia G., Development and mechanisms of fetal hypoxia in severe fetal growth restriction Placenta 2007 28 7 714 723
29. Giussani D. A., Salinas C. E., Villena M., Blanco C. E., The role of oxygen in prenatal growth: studies in the chick embryo Journal of Physiology 2007 585 3 911 917
30. de Grauw T. J., Myers R. E., Scott W. J., Fetal growth retardation in rats from different levels of hypoxia Biology of the Neonate 1986 49 2 85 89
31. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 Cell 2006 127 6 1109 1122
32. Oak S., Tran C., Castillo M.-O., Thamotharan S., Thamotharan M., Devaskar S. U., Peroxisome proliferator-activated receptor- agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring American Journal of Physiology 2009 297 2 E514 E524
33. Brunmair B., Staniek K., Drig J., Szcs Z., Stadlbauer K., Marian V., Gras F., Anderwald C., Nohl H., Waldhusl W., Frnsinn C., Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids Diabetologia 2006 49 11 2713 2722
34. Dressel U., Allen T. L., Pippal J. B., Rohde P. R., Lau P., Muscat G. E. O., The peroxisome proliferator-activated receptor / agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells Molecular Endocrinology 2003 17 12 2477 2493
35. Sun C., Zhang F., Ge X., Yan T., Chen X., Shi X., Zhai Q., SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B Cell Metabolism 2007 6 4 307 319
36. Yun Z., Lin Q., Giaccia A. J., Adaptive myogenesis under hypoxia Molecular and Cellular Biology 2005 25 8 3040 3055
37. Arthur P. G., Giles J. J., Wakeford C. M., Protein synthesis during oxygen conformance and severe hypoxia in the mouse muscle cell line C2C12 Biochimica et Biophysica Acta 2000 1475 1 83 89
38. Casanello P., Krause B., Torres E., Gallardo V., Gonzlez M., Prieto C., Escudero C., Faras M., Sobrevia L., Reduced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia Placenta 2009 30 7 625 633
39. Son C., Hosoda K., Matsuda J., Fujikura J., Yonemitsu S., Iwakura H., Masuzaki H., Ogawa Y., Hayashi T., Itoh H., Nishimura H., Inoue G., Yoshimasa Y., Yamori Y., Nakao K., Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes Endocrinology 2001 142 10 4189 4194
40. Chang E. P., Kim M.-J., Jong H. L., Min B.-I., Bae H., Choe W., Kim S.-S., Ha J., Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase Experimental and Molecular Medicine 2007 39 2 222 229
41. Pfaffl M. W., Georgieva T. M., Georgiev I. P., Ontsouka E., Hageleit M., Blum J. W., Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species Domestic Animal Endocrinology 2002 22 2 91 102
42. Postovit L.-M., Abbott D. E., Payne S. L., Wheaton W. W., Margaryan N. V., Sullivan R., Jansen M. K., Csiszar K., Hendrix M. J. C., Kirschmann D. A., Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration Journal of Cellular Biochemistry 2008 103 5 1369 1378
43. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., De Oliveira R. M., Leid M., McBurney M. W., Guarente L., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR- Nature 2004 429 6993 771 776
44. Han L., Zhou R., Niu J., McNutt M. A., Wang P., Tong T., SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Research. In press
45. Wang Y.-X., Lee C.-H., Tiep S., Yu R. T., Ham J., Kang H., Evans R. M., Peroxisome-proliferator-activated receptor activates fat metabolism to prevent obesity Cell 2003 113 2 159 170
46. Puigserver P., Spiegelman B. M., Peroxisome proliferator-activated receptor- coactivator 1 (PGC-1 ): transcriptional coactivator and metabolic regulator Endocrine Reviews 2003 24 1 78 90
47. Della-Morte D., Dave K. R., DeFazio R. A., Bao Y. C., Raval A. P., Perez-Pinzon M. A., Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway Neuroscience 2009 159 3 993 1002
48. Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L.-L., Scherer B., Sinclair D. A., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 2003 425 6954 191 196
49. Huss J. M., Levy F. H., Kelly D. P., Hypoxia inhibits the peroxisome proliferator-activated receptor /retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation The Journal of Biological Chemistry 2001 276 29 27605 27612
50. Belanger A. J., Luo Z., Vincent K. A., Akita G. Y., Cheng S. H., Gregory R. J., Jiang C., Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor /retinoid X receptor Biochemical and Biophysical Research Communications 2007 364 3 567 572
51. Narravula S., Colgan S. P., Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor expression during hypoxia The Journal of Immunology 2001 166 12 7543 7548
52. Schietke R., Warnecke C., Wacker I., Schdel J., Mole D. R., Campean V., Amann K., Goppelt-Struebe M., Behrens J., Eckardt K.-U., Wiesener M. S., The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in Hypoxia: insights into cellular transformation processes mediated by HIF-1 The Journal of Biological Chemistry 2010 285 9 6658 6669
53. Lim J. H., Lee Y. M., Chun Y. S., Chen J., Kim J. E., Park J. W., Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha Molecular cell 2010 38 6 864 878
54. Zhang Q., Wang S.-Y., Nottke A. C., Rocheleau J. V., Piston D. W., Goodman R. H., Redox sensor CtBP mediates hypoxia-induced tumor cell migration Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9029 9033
55. Zhang Q., Wang S.-Y., Fleuriel C., Leprince D., Rocheleau J. V., Piston D. W., Goodman R. H., Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 829 833
56. Wouters B. G., Van Den Beucken T., Magagnin M. G., Koritzinsky M., Fels D., Koumenis C., Control of the hypoxic response through regulation of mRNA translation Seminars in Cell and Developmental Biology 2005 16 4-5 487 501
57. Essop M. F., Razeghi P., McLeod C., Young M. E., Taegtmeyer H., Sack M. N., Hypoxia-induced decrease of UCP3 gene expression in rat heart parallels metabolic gene switching but fails to affect mitochondrial respiratory coupling Biochemical and Biophysical Research Communications 2004 314 2 561 564
58. Trujillo M. E., Scherer P. E., Adipose tissue-derived factors: impact on health and disease Endocrine Reviews 2006 27 7 762 778
59. Hammarstedt A., Smith U., Thiazolidinediones (PPAR ligands) increase IRS-1, UCP-2 and C/EBP expression, but not transdifferentiation, in L6 muscle cells Diabetologia 2003 46 1 48 52
60. Choi J. H., Banks A. S., Estall J. L., Kajimura S., Bostrm P., Laznik D., Ruas J. L., Chalmers M. J., Kamenecka T. M., Blher M., Griffin P. R., Spiegelman B. M., Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR 3 by Cdk5 Nature 2010 466 7305 451 456
61. Yu Y. H., Liu B. H., Mersmann H. J., Ding S. T., Porcine peroxisome proliferator-activated receptor induces transdifferentiation of myocytes into adipocytes Journal of Animal Science 2006 84 10 2655 2665
62. Shen Z., Liang X., Rogers C. Q., Rideout D., You M., Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice American Journal of Physiology 2010 298 3 G364 G374
63. Cheng G., Zhang X., Gao D., Jiang X., Dong W., Resveratrol inhibits MMP-9 expression by up-regulating PPAR expression in an oxygen glucose deprivation-exposed neuron model Neuroscience Letters 2009 451 2 105 108
64. Wu H., Liang X., Fang Y., Qin X., Zhang Y., Liu J., Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 expression in colon carcinoma cells Biomedicine and Pharmacotherapy 2008 62 9 613 621
65. Zhang Q., Tang X., Lu Q. Y., Zhang Z. F., Brown J., Le A. D., Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1 and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells Molecular Cancer Therapeutics 2005 4 10 1465 1474